Cancers, Vol. 16, Pages 1440: Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations

In conclusion, considering the escalating use of ICIs, this area of research necessitates additional clinical studies and practical insights, especially the development of biomarkers for predicting immune toxicities. In addition, there is a need for heightened education for both clinicians and patients to enhance understanding and awareness.

Source: Cancers - April 8, 2024 Category: Cancer & Oncology Authors: Silvia Casagrande Giulia Boscato Sopetto Giovanni Bertalot Roberto Bortolotti Vito Racanelli Orazio Caffo Bruno Giometto Alvise Berti Antonello Veccia Tags: Review Source Type: research